Introduction
The pathology of salivary and lacrimal gland neoplasms is complex with more than 30 entities recognized based on the 2005 WHO Classification of Tumours: Pathology and Genetics of Head and Neck Tumors. We recently completed a review of 118 lacrimal gland neoplasms obtained from four centres. 1 Most numerous were 57 pleomorphic adenomas (PA). Of the 59 malignant neoplasms, the most common was adenoid cystic carcinoma (38), followed by carcinoma ex pleomorphic adenoma (9) , adenocarcinoma NOS (3) and others (9; 1 or 2 cases each). This is one of the largest reviews of epithelial neoplasms of the lacrimal gland and highlights one of the problems of learning about lacrimal gland tumors, the small numbers of cases seen at one institution.
A note on salivary versus lacrimal
Most of the molecular information about epithelial lacrimal neoplasms comes from the study of salivary gland neoplasms, just by virtue of their greater numbers. In this presentation I have assumed that molecular findings of epithelial neoplasms of the salivary glands can be applied to lacrimal neoplasms of the same histological type. However, there is one piece of information that corroborates this assumption. In 1994 Hrynchak, White, Berean, Horsman reported the cytogenetic findings of 7 lacrimal gland neoplasms: 4 PAs, 1 CaPA, 2 ACCs. 2 The cytogenetic findings were similar to those in salivary gland neoplasms. The PAs had breakpoints in 3p/3q, 8p/8q, 12q, similar to those in salivary glands. One ACC had a t(6;9)(q23;p22), a translocation seen in a minority of salivary ACCs, but one that has become highly important in understanding the pathogenesis of these neoplasms. The other ACC had a complex karyotype including trisomy 5 and 7.
ACC with High Grade Transformation (dedifferentiation)
The molecular changes in ACC are not well understood; from array CGH most common losses are in 1p32-36, 6q23-27 and 12q12-14; most common gains are of 8q24 and 22q13.
Deletions in 1p32-26 are associated with an aggressive course, but not proven to be independent factor yet. 3 ACC with dedifferentiation is now known as ACC with high-grade transformation amplification and p53 is often overexpressed. 4 In our recent review of 118 lacrimal gland neoplasms, 2/38 ACC had HGT. 1 t(6;9) and MYB-NFIB gene fusion There is frequent loss of 6q associated with translocations in ACC. The t(6;9) is found in 14%, some as the sole change as in our lacrimal ACC. In 43%, 9p is partner. In cases with this translocation a MYB-NFIB fusion gene has been identified. This results in a fusion transcript with loss of the MYB 3' untranslated region, leading to high MYB expression. 5 Mitani et al. 6 studied 123 salivary neoplasms and found the MYB-NFIB fusion in 20/72 (28%) primary The major consequence of fusion is a dramatic increase in the expression of MYB protein that is attributed to loss of MYB sequences containing regulatory binding sites for miRNA.
These findings have been corroborated by West et al. 7 Her2 and salivary/lacrimal neoplasms The Her signaling network consists of four receptors and their ligands, of which Her2 and EGFR (Her1) are the most widely studied. 8 Vidal et al. 9 
